Trial intelligence / Profile preview

Chemo-Radiotherapy in Advanced Nasopharyngeal Cancer (S9715)

NCT00002999Phase 2Withdrawn

Sponsor
SWOG Cancer Research Network
Modality
Small Molecules
01

Overview

A Phase 2 trial of cisplatin, fluorouracil in nasopharyngeal carcinoma (NPC), sponsored by SWOG Cancer Research Network. Status: withdrawn.

02

Drugs

cisplatinfluorouracil
03

Conditions

nasopharyngeal carcinoma (NPC)

Beyond the preview

Go deeper on NCT00002999.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002999.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call